Alessandro Rizzo

107PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (107)

|Mar 28, 2026
Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS).

Alessio Giubellino, Gerardo Cazzato, Mario Della Mura

|Mar 26, 2026
Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience.

Massimiliano Salati, Eleonora Borghi, Riccardo Cuoghi Costantini

|Mar 09, 2026
Unlocking New Possibilities: Dual Immune Blockade in Brain Metastases from Rare Tumors.

Angela Dalia Ricci, Alessandro Rizzo

|Mar 05, 2026
Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?

Lorenza Di Marco, Federica Valerio, Yuri Maculan

|Feb 12, 2026
Association Between Systemic Immune-Inflammatory Index (SII) and Cancer Grading and Staging: Evidence from the Current Scientific Literature.

Alessandro Rizzo, Elsa Vitale, Lorenza Maistrello

|Dec 30, 2025
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives.

Martina Astore, Laura Fabbri, Andrea Monte

Pageof 18

Frequent Collaborators

22 joint publications

Francesco Massari

14 joint publications

Veronica Mollica

9 joint publications

Angela Dalia Ricci

7 joint publications

Giorgio Frega